TQ-A3334

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Tongji Hospital

Conditions

Chronic Hepatitis BChronic Hepatitis bNon-small Cell Lung Cancer

Phase 1

A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Non-small Cell Lung Cancer

Start: 2020-07-06End: 2021-01-31Target: 40Updated: 2020-07-08

Phase 2

A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Hepatitis B

Start: 2019-11-18End: 2021-12-31Target: 12Updated: 2019-12-16

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)

Tongji HospitalChronic Hepatitis b

Start: 2020-01-01End: 2021-06-30Target: 30Updated: 2019-12-19